A single dose of Pfizer’s coronavirus vaccine may offer sufficient protection against the virus for people who have already had COVID-19, two studies show.
“This could potentially accelerate vaccine rollout,” researchers at University College of London and Public Health England said in the first study. “With increasing variants, wider coverage without compromising vaccine-induced immunity could help reduce variant emergence.”
Read More